Jasper J. Brugts

Jun 20, 2024 | onlinelibrary.wiley.com | Jasper J. Brugts

Invited Editorial Remote haemodynamic monitoring and the next step: Involving the patient in the self-management of heart failure First published: 20 June 2024 No abstract is available for this article. References 1Meerkin D, Perl L, Hasin T, Petriashvili S, Kurashvili L, Metreveli M, et al.; VECTOR-HF I and IIa Trials Investigators. Physician-directed patient self-management in heart failure using left atrial pressure: Interim insights from the VECTOR-HF I and IIa studies.

May 13, 2024 | cfrjournal.com | Jasper J. Brugts |Michael S. Kiernan |Finn Gustafsson |Muthiah Vaduganathan

HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672). MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation, irrespective of ejection fraction.

Apr 5, 2023 | jacc.org | Stephen Greene |Johann Bauersachs |Jasper J. Brugts |Justin A. Ezekowitz

JACC Journals › JACC › Archives › Vol. 82 No. 6 AbstractDespite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population.